Genomic Valley Biotech Ltd

NSE: BSE: 539206

₹29.10

(1.29%)

Sun, 27 Sept 2026, 00:26 am

MTF 5xInvest in Genomic Valley Biotech Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)0

PE Ratio0

Dividend0

Health Technology

Biotechnology

24.5K

Genomic Valley Biotech News

Genomic Valley Biotech reports FY26 results

Genomic Valley Biotech reported a net profit of ₹3,03,041 for FY26, a turnaround from the prior year. Revenue from operations fell to ₹26,75,000.

29 May 2026

companies

Genomic Valley Biotech Board Meet Set for May 29

Genomic Valley Biotech schedules board meeting on May 29, 2026, to consider audited standalone financial results for Q4 and full year ended March 31, 2026.

18 May 2026

companies

Genomic Valley Biotech Files Q4 FY26 SEBI Certificate

Genomic Valley Biotech Limited submits mandatory quarterly certificate to BSE pursuant to SEBI Depositories Regulations for quarter ended March 31st, 2026, confirming compliance with dematerialization requirements.

14 Apr 2026

companies

Genomic Valley Biotech Files SEBI Declaration for FY26

Genomic Valley Biotech Limited submitted its annual declaration under SEBI Takeover Regulations, confirming no encumbrance by promoters during FY26. The declaration was filed by promoter Yogesh Agrawal.

03 Apr 2026

companies

Genomic Valley Biotech Files SEBI Declaration for FY26

01 Apr 2026

companies

Showing 1–5 of 8

Rows per page:

Market Current News

JINDAL SUPREME (INDIA) LIMITED

Craft Emerging Market Fund acquires 5.79% in Jindal Supreme

Craft Emerging Market Fund PCC acquired 29.53 lakh shares of Jindal Supreme India Ltd via IPO anchor investment, taking its stake to 5.79%. The acquisition was disclosed under SEBI SAST regulations on September 22, 2026.

26 Sept 2026

ipo

XTRANET TECHNOLOGIES LIMITED

Xtranet Technologies updates CIN and listing status

Xtranet Technologies Limited updated its Corporate Identification Number and MCA listing status to 'Yes' following equity share listings on BSE and NSE.

25 Sept 2026

ipo

PRESTIGE ESTATES PROJECTS LTD.

Prestige Estates subsidiary PHVL withdraws draft IPO prospectus

Prestige Estates Projects' subsidiary PHVL has cancelled its Draft Red Herring Prospectus citing strategic reasons and uncertain market conditions. A new prospectus may be filed later.

25 Sept 2026

ipo

Runwal Enterprises IPO Day 1: Subscribed 0.03x

Runwal Enterprises IPO sees muted demand on Day 1 with overall subscription at 0.03x. QIB interest remains negligible while Retail leads category-wise response.

25 Sept 2026

ipo

Pooja Logistics IPO Day 3: Subscribed 0.59x

Pooja Logistics IPO sees sluggish demand on final day with overall subscription at 0.59x. Retail leads at 0.92x while QIB interest remains zero.

25 Sept 2026

ipo

Showing 1–5 of 94419

Rows per page: